Market Research Report
Bone and Joint Health Supplements
|Published by||Global Industry Analysts, Inc.||Product code||557325|
|Published||Content info||300 Pages
Delivery time: 1-2 business days
|Bone and Joint Health Supplements|
|Published: July 1, 2020||Content info: 300 Pages||
Global Bone and Joint Health Supplements Market to Reach US$14.7 Billion by the Year 2027
Amid the COVID-19 crisis, the global market for Bone and Joint Health Supplements estimated at US$9.9 Billion in the year 2020, is projected to reach a revised size of US$14.7 Billion by 2027, growing at a CAGR of 5.8% over the period 2020-2027.Joint Supplements, one of the segments analyzed in the report, is projected to grow at a 6.4% CAGR to reach US$9.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Bone Supplements segment is readjusted to a revised 5% CAGR for the next 7-year period. This segment currently accounts for a 37.5% share of the global Bone and Joint Health Supplements market.
The U.S. Accounts for Over 27.1% of Global Market Size in 2020, While China is Forecast to Grow at a 9% CAGR for the Period of 2020-2027
The Bone and Joint Health Supplements market in the U.S. is estimated at US$2.7 Billion in the year 2020. The country currently accounts for a 27.07% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$3.1 Billion in the year 2027 trailing a CAGR of 9% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 5.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR while Rest of European market (as defined in the study) will reach US$3.1 Billion by the year 2027.We bring years of research experience to this 18th edition of our report. The 300-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others,